BD Launches New Cell Analyzer Configurations to Bring Cutting-Edge Capabilities to Labs of All Sizes

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the global ...

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth

Cytek Biosciences has recurring revenue growth, improving margins, and ample cash that should continue compounding shareholder value over time. See why CTKB is a Buy.
MarketWatch

Europe Flow Cytometry Market Analysis and Forecast Report 2025-2035: Rising Demand for Compact, Benchtop Flow Cytometers Suitable for Decentralized Labs and Point-of-care ...

The "Europe Flow Cytometry Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The Europe flow cytometry market is projected to reach $2.04 billion by ...
The Motley Fool

What Is Free Cash Flow to Equity (FCFE)? Formula and Example

FCFE shows a company's money left after paying bills, essential for assessing financial health. To calculate FCFE: net income + depreciation - capex - working capital + net debt. Positive FCFE ...
Wall Street Journal

Cash Flow Analysis: How It Works and Why It Matters in 2025

Learn how to tell if your business could be facing a cash crunch Written By Written by Staff Senior Editor, Buy Side Miranda Marquit is a staff senior personal finance editor for Buy Side. Edited By ...
Nasdaq

Why Free Cash Flow Drives Superior Stock Performance

According to the legendary investor Warren Buffett, free cash flow—the cash remaining after a company has covered expenses, interest, taxes, and long-term investments—is the most crucial valuation ...